Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Antibody-mediated rejection of renal allografts: diagnostic pitfalls and challenges

M. Novotný, M. Kment, O. Viklický

. 2021 ; 70 (Suppl. 4) : S551-S565. [pub] 20211230

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22009503

Antibody-mediated rejection (ABMR) is a major obstacle to the long-term success in kidney transplantation. Diagnosis of ABMR is determined according to the internationally recognized Banff criteria. However, a significant proportion of patients does not meet all the defined criteria, and the outcome of such cases remains poorly understood. The histology of ABMR frequently lacks sensitivity and specificity. More importantly, mixed forms of ABMR and T cell-mediated rejection as well as findings of nonspecific injury are common in clinical settings. Donor-specific anti-HLA antibodies (DSA) are detectable only in half of the ABMR cases by histology. Prognostic role of non-HLA antibodies against various endothelial proteins has been discussed. Antibody independent NK cell activation reflecting killer-cells' inhibitory receptor incompatibility is suggested in microvascular inflammation in DSA negative patients. Molecular assessment of ABMR has been prioritized to overcome high interobserver variability and improve diagnostics in mixed forms of rejections and in DSA negative cases. Finally, donor-derived cell-free DNA detected in a recipient's peripheral blood sample has been proposed as a noninvasive marker for diagnosis of graft rejection, and thus might serve as a liquid biopsy in the near future. Despite all achievements, diagnosing ABMR in kidney allografts remains to be a challenge in a significant number of cases.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22009503
003      
CZ-PrNML
005      
20250610144312.0
007      
ta
008      
220419s2021 xr a f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934801 $2 doi
035    __
$a (PubMed)35199543
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Novotný, Marek $u Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $7 xx0213626 $u 1st Medical Faculty, Charles University, Prague, Czech Republic
245    10
$a Antibody-mediated rejection of renal allografts: diagnostic pitfalls and challenges / $c M. Novotný, M. Kment, O. Viklický
520    9_
$a Antibody-mediated rejection (ABMR) is a major obstacle to the long-term success in kidney transplantation. Diagnosis of ABMR is determined according to the internationally recognized Banff criteria. However, a significant proportion of patients does not meet all the defined criteria, and the outcome of such cases remains poorly understood. The histology of ABMR frequently lacks sensitivity and specificity. More importantly, mixed forms of ABMR and T cell-mediated rejection as well as findings of nonspecific injury are common in clinical settings. Donor-specific anti-HLA antibodies (DSA) are detectable only in half of the ABMR cases by histology. Prognostic role of non-HLA antibodies against various endothelial proteins has been discussed. Antibody independent NK cell activation reflecting killer-cells' inhibitory receptor incompatibility is suggested in microvascular inflammation in DSA negative patients. Molecular assessment of ABMR has been prioritized to overcome high interobserver variability and improve diagnostics in mixed forms of rejections and in DSA negative cases. Finally, donor-derived cell-free DNA detected in a recipient's peripheral blood sample has been proposed as a noninvasive marker for diagnosis of graft rejection, and thus might serve as a liquid biopsy in the near future. Despite all achievements, diagnosing ABMR in kidney allografts remains to be a challenge in a significant number of cases.
650    _2
$a alografty $7 D064591
650    _2
$a rejekce štěpu $x diagnóza $7 D006084
650    _2
$a lidé $7 D006801
650    _2
$a isoprotilátky $7 D007518
650    _2
$a ledviny $x patologie $7 D007668
650    12
$a transplantace ledvin $x škodlivé účinky $7 D016030
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kment, Martin $7 xx0171983 $u Department of Clinical and Transplant Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Viklický, Ondřej, $d 1966- $7 nlk20050170291 $u Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u 1st Medical Faculty, Charles University, Prague, Czech Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 70, Suppl. 4 (2021), s. S551-S565
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35199543 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20220419 $b ABA008
991    __
$a 20250610144305 $b ABA008
999    __
$a ok $b bmc $g 1797011 $s 1160701
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 70 $c Suppl. 4 $d S551-S565 $e 20211230 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK124 $a Pubmed-20220419

Najít záznam

Citační ukazatele

Možnosti archivace